Treatment of refractory hand eczema by dupilumab: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of refractory hand eczema by dupilumab: A case report

Published:2024-02-25 Issue:7 Volume:63 Page:972-974
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Dong Hanyue¹,Chen Wei¹,Liang Bo²³,Li Hongmin¹^ORCID

Affiliation:

1. Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing China

2. Department of Dermatology and Venereology The First Affiliated Hospital, Anhui Medical University Hefei Anhui China

3. Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education Hefei China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.17098

Reference5 articles.

1. Hand Eczema

2. Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study

3. Three cases of non‐atopic hyperkeratotic hand eczema treated with dupilumab

4. Severe treatment‐resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab

5. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editor's Highlights – July 2024;International Journal of Dermatology;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP